Because myeloid cells have also been found to behave like myofibroblasts under certain circumstances and contribute to renal fibrosis49, these data argue for the benefit of targeting MRTF-A, regardless of its origin, in the treatment of renal fibrosis. This evidence concerns the gene MRTFA and renal fibrosis.